GlaxoSmithKline | GSK - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
Almirall EUR 2.71M 580K 2025-12
argenx SE USD 44.87M 2.17M 2025-12
AstraZeneca USD 73M 62M 2026-03
Bayer EUR 169M 39M 2025-12
Biogen USD 37.9M 700K 2026-03
Eli Lilly USD 65M 25M 2025-09
Fresenius Medical Care EUR 14.62M 999K 2026-03
Genmab DKK 25M 8M 2025-06
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 26M 24M 2025-09
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
Lakefront Biotherapeutics EUR 13.56M 991K 2026-03
Merck EUR 21M 6M 2025-12
Merck USD 69M 27M 2025-12
Pfizer USD 115M 51M 2026-03
Philips EUR 8M 13M 2025-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Smith & Nephew USD 15M 6M 2024-12